Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

723 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
S2k guideline for the treatment of hidradenitis suppurativa / acne inversa - Short version.
Zouboulis CC, Bechara FG, Fritz K, Goebeler M, Hetzer FH, Just E, Kirsten N, Kokolakis G, Kurzen H, Nikolakis G, Pinter A, Podda M, Rosinski K, Schneider-Burrus S, Taube KM, Volz T, Winkler T, Kristandt A, Presser D, Zouboulis VA. Zouboulis CC, et al. J Dtsch Dermatol Ges. 2024 May 21. doi: 10.1111/ddg.15412. Online ahead of print. J Dtsch Dermatol Ges. 2024. PMID: 38770982
Development of the acne-specific quality of life questionnaire Quality of Life Relevance-Acne.
Chernyshov PV, Sampogna F, Raimondi G, Zouboulis CC, Boffa MJ, Marron SE, Manolache L, Pustišek N, Bettoli V, Koumaki D, Bewley AP, Dreno B, Tomas-Aragones L. Chernyshov PV, et al. Among authors: zouboulis cc. JAAD Int. 2024 Mar 25;16:9-17. doi: 10.1016/j.jdin.2024.03.007. eCollection 2024 Sep. JAAD Int. 2024. PMID: 38764481 Free PMC article.
Acne lesions cycle.
Zouboulis CC, Kollias N. Zouboulis CC, et al. J Eur Acad Dermatol Venereol. 2024 May 2. doi: 10.1111/jdv.20061. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38695690 No abstract available.
TRPV3 promotes sebocyte inflammation via transcriptional modulating TLR2 in acne.
Wei Z, Gao M, Liu Y, Zeng R, Liu J, Sun S, Li S, Hu L, Xiang R, Mo R, Song Z, Chen Z, Bao D, Hua D, Zouboulis CC, Feng Y, Li J, Yang Y. Wei Z, et al. Among authors: zouboulis cc. Biochim Biophys Acta Mol Basis Dis. 2024 Jun;1870(5):167195. doi: 10.1016/j.bbadis.2024.167195. Epub 2024 Apr 20. Biochim Biophys Acta Mol Basis Dis. 2024. PMID: 38648901
Discrepancies in hidradenitis suppurativa lesion characterization by providers and patients.
Greenlund L, Herzog C, Wendland Z, Rypka K, Frew JW, Kirby JS, Alavi A, Khalid B, Lowes MA, Garg A, Marzano AV, Zouboulis CC, Tzellos T, Jaleel T, Goldfarb N. Greenlund L, et al. Among authors: zouboulis cc. J Eur Acad Dermatol Venereol. 2024 Apr 10. doi: 10.1111/jdv.19999. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38595320
Proof-of-concept study exploring the effect of spesolimab in patients with moderate-to-severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled clinical trial.
Alavi A, Prens E, Kimball AB, Frew JW, Krueger JG, Mukhopadhyay S, Gao H, Ranganathan U, Ivanoff NB, Hernandez Daly AC, Zouboulis CC. Alavi A, et al. Among authors: zouboulis cc. Br J Dermatol. 2024 Apr 5:ljae144. doi: 10.1093/bjd/ljae144. Online ahead of print. Br J Dermatol. 2024. PMID: 38576350
Primary Cutaneous Melanoma-Management in 2024.
Dixon AJ, Sladden M, Zouboulis CC, Popescu CM, Nirenberg A, Steinman HK, Longo C, Dixon ZL, Thomas JM. Dixon AJ, et al. Among authors: zouboulis cc. J Clin Med. 2024 Mar 11;13(6):1607. doi: 10.3390/jcm13061607. J Clin Med. 2024. PMID: 38541831 Free PMC article.
Secukinumab in patients with moderate-to-severe hidradenitis suppurativa based on prior biologic exposure: an efficacy and safety analysis from the SUNSHINE and SUNRISE phase III trials.
Zouboulis CC, Passeron T, Pariser D, Wozniak MB, Li X, Uhlmann L, Lobach I, Martinez AL, Ravichandran S, Alarcon I, Offidani A, Alam MS, Mendes-Bastos P. Zouboulis CC, et al. Br J Dermatol. 2024 May 17;190(6):836-845. doi: 10.1093/bjd/ljae098. Br J Dermatol. 2024. PMID: 38470171 Clinical Trial.
Spatial transcriptomics reveals altered lipid metabolism and inflammation-related gene expression of sebaceous glands in psoriasis and atopic dermatitis.
Seiringer P, Hillig C, Schäbitz A, Jargosch M, Pilz AC, Eyerich S, Szegedi A, Sochorová M, Gruber F, Zouboulis CC, Biedermann T, Menden MP, Eyerich K, Törőcsik D. Seiringer P, et al. Among authors: zouboulis cc. Front Immunol. 2024 Feb 16;15:1334844. doi: 10.3389/fimmu.2024.1334844. eCollection 2024. Front Immunol. 2024. PMID: 38433843 Free PMC article.
723 results